ArticleAdvanced materials (Deerfield Beach, Fla.)2025
Conjugation Pathway of Benzobisoxazoles in Polymer Donors Mediates the Charge Management and Enables Organic Solar Cells with Record Certified Efficiency.
Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rational Asymmetric Acceptor Engineering via Unidirectional Terminal π-Extension and Optimizing Alkyl Branching Sites Affords a Binary Photovoltaic Efficiency of 20.7% by Suppressed Nonradiative Energy Loss.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Conjugation Pathway of Benzobisoxazoles in Polymer Donors Mediates the Charge Management and Enables Organic Solar Cells with Record Certified Efficiency.Advanced materials (Deerfield Beach, Fla.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Charge management plays a pivotal role in achieving high-performance bulk heterojunction (BHJ) organic solar cells (OSCs). In this study, two efficient polymer donors are designed, P[4,8]BBO and P[2,6]BBO, by regulating the conjugation pathways of benzobisoxazoles (BBO) through 4,8- and 2,6-linkages, respectively. Comparing to P[2,6]BBO, the isomer of conjugation pathway has been proved to enable P[4,8]BBO a shallower highest occupied molecular orbital (HOMO) energy level of -5.20 eV, significantly enhanced luminescence efficiency, and reduced aggregation property. These improvements lead to a dramatic increase in device efficiencies from 2.6% for P[2,6]BBO:eC9-2Cl to 19.0% for P[4,8]BBO:eC9-2Cl. The combined characterizations show that a better comprehensive charge management can be reached in P[4,8]BBO:eC9-2Cl-based OSCs, yielding a significantly higher short-circuit current density (J
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.